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Abstract
Fluorescent tracer dyes represent an important class of sub-cellular probes and allow the examination of cellular processes
in real-time with minimal impact upon these processes. Such tracer dyes are becoming increasingly used for the
examination of membrane transport processes, as they are easy-to-use, cost effective probe substrates for a number of
membrane protein transporters. Rhodamine 123, a member of the rhodamine family of flurone dyes, has been used to
examine membrane transport by the ABCB1 gene product, MDR1. MDR1 is viewed as the archetypal drug transport protein,
and is able to efflux a large number of clinically relevant drugs. In addition, ectopic activity of MDR1 has been associated
with the development of multiple drug resistance phenotype, which results in a poor patient response to therapeutic
intervention. It is thus important to be able to examine the potential for novel compounds to be MDR1 substrates. Given
the increasing use rhodamine 123 as a tracer dye for MDR1, a full characterisation of its spectral properties in a range of in
vitro assay-relevant media is warranted. Herein, we determine lmax for excitation and emission or rhodamine 123 and its
metabolite rhodamine 110 in commonly used solvents and extraction buffers, demonstrating that fluorescence is highly
dependent on the chemical environment: Optimal parameters are 1% (v/v) methanol in HBSS, with lex = 505 nm,
lem = 525 nm. We characterise the uptake of rhodamine 123 into cells, via both passive and active processes, and
demonstrate that this occurs primarily through OATP1A2-mediated facilitated transport at concentrations below 2 mM, and
via micelle-mediated passive diffusion above this. Finally, we quantify the intracellular sequestration and metabolism of
rhodamine 123, demonstrating that these are both cell line-dependent factors that may influence the interpretation of
transport assays.
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Introduction
Within the last decade there has been an increased need for the
development of reporter dyes that can be used to examine
biological processes within the cellular context. This need is driven
by the ability of such dyes to allow the real-time monitoring of
cellular processes with regard to both sub-cellular localisation,
biological functionality and kinetic parameters [1]; such data can
then be used for both in vitro and in silico mechanistic studies
[2,3,4,5], as well as the optimisation of rapid drug screening assays
[6]. One such group of tracer dyes are the rhodamine family of
flurone dyes, which have multiple applications in fluorescence
microscopy, flow cytometry, fluorescence correlation spectroscopy
and ELISA. Commonly used flurone dyes include rhodamine-123
(R123), Rhodamine B and Rhodamine 6G, as well as the further
modified carboxytetramethylrhodamine (TAMRA), tetramethylr-
hodamine (TMR) and Texas Red (figure 1). Within this family,
R123 has been used extensively as both an inhibitor of
mitochondrial function [7,8] and a tracer for membrane transport
[9,10,11]. R123 has many advantages as a biological tracer,
including commercial availability, low cost, high quantum yield,
non-invasive detection and low interference with underlying
metabolic processes [8]. However, this utility comes with a
number of caveats, such as the observation that R123 fluorescence
deviates from linearity above 5 mM in aqueous solution, with the
intensity diminishing toward zero at higher concentrations [7];
indeed, R123-seqestration into membranes in vitro has been
suggested to further reduce the upper limit of linearity to 1 mM
[7]. It is therefore important to fully characterize the spectroscopic
properties of R123 under a range of commonly used in vitro assay
conditions to ensure optimal utility of this important tracer dye
within in vitro transport assays.
The requirement for an accurate quantification of the transport
of chemicals across biological membranes has come increasingly to
the fore, with the important role of membrane transport proteins
being highlighted [12]. This transport impacts upon the
absorption, distribution and excretion processes directly, and
indirectly determine metabolic fate through the control of
chemical access to intracellular metabolic enzyme systems. The
protein-meditated transport of drug-like chemicals across biolog-
ical membranes is predominantly undertaken by the solute carrier
(SLC) and ATP-binding cassette (ABC) superfamilies of proteins
[13]. SLC family members encompass both uptake and efflux
transporters, whereas ABC transporters are exclusively efflux
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transporters in mammals, with both families utilising energy to
transport substrates against their concentration gradient [13].
Together, these drug transport proteins are important determi-
nants of chemical pharmacokinetics [14,15], having a large impact
on intracellular concentrations, and hence biological response. In
addition to this important role in normophysiology, atopic
expression of drug transport proteins is observed in many tumours
[16,17]; for example, increased expression of MDR1 is associated
with a reduced response to therapy in breast cancer [18],
presumably due to increased efflux of chemotherapeutic agents
from the tumour cells. Given the need to better understand, and
quantify, transport processes, tracer dyes are being increasingly
used to examine these processes, with R123, Fluo-3 and
carboxydichlorofluroscein being increasingly used to study
MDR1-, OATP1B3- and MRP2- mediated transport, respectively
[4,19,20]. Herein, we examine the physiochemical properties of
R123, and characterize the optimal conditions for its use as a
tracer dye to quantify MDR1-mediated transport. This analysis
includes the characterization of optimal emission and excitation
wavelengths for R123; the effect of common solvents used for in
vitro assays; the stability or R123 (both photo- and metabolic), and
the membrane transport characteristics. Together, these data
demonstrate the optimal conditions for use of R123 as a tracer dye
in vitro to quantify MDR1-mediated drug efflux. In addition, such
work will facilitate the further development of these assays, which
are important to fully understand the intracellular pharmacoki-
netics of administered therapeutics.
Results and Discussion
Excitation and Emission Characteristics of R123
In order to accurately assess the levels of both R123 and its
primary metabolite R110 we first determined the excitation (lex)
and emission (lem) maxima for both compounds. 1 mM R123 and
R110 solutions prepared in 1% (v/v) methanol in Hank’s buffered
saline solution (HBSS), produced maxima absorbance values of
502 nm and 497 nm respectively (Figure 2a): As the R123
certificate of analysis suggests a lex (MeOH) of 507 nm (Sigma-
Aldrich, Poole, UK), we selected an intermediate of 505 nm for all
subsequent experiments. Using lex = 505 nm, emission spectra
were obtained for R123 and R110 under the same solvent
composition, determining maxima lem of 525 nm and 520 nm
for R123 and R110 emission, respectively (figure 2b). Following
these initial experiments, all subsequent experiments were
undertaken using 1% (v/v) methanol in HBSS as the medium,
and lex = 505 nm, lem = 525 nm unless otherwise stated. It is
interesting to note that under these conditions, R123 exhibited
both higher absorption and emission intensities than R110 when
prepared as equimolar solutions, consistent with the work of Jager
and colleagues [21].
It is well established that the local chemical environment may
significantly impact on the spectroscopic properties of a flurophore
[22], and hence we next investigated the impact of commonly used
solvents on fluorescence emmission. 1 mM R123 and R110
solutions were prepared in 1% (v/v) solvent in HBSS, using a
variety of analytical grade laboratory solvents. Figure 2c and 2d
demonstrate the impact of these solvents on lem for R123 and
R110, respectively. In general, all other solvents produced a lower
quantum yield than methanol, with this effect more pronounced
for R110. In addition, the maxima for lem also differed slightly
depending upon the solvent, although this was again more
pronounced for R110 than R123. To further examine the
relationship between chemical environment and quantum yield,
we examined the correlation between solvent dielectric constant
and the quantum yield at the lem maxima for each solvent
(figure 2e). Quantum yield for both R123 and R110 increases
linearly with solvent dielectric constant until e<30, whereupon no
further increases in quantum yield are observed. As methanol has
a dielectric constant of 33, this is consistent with its selection as the
solvent of choice for R123. It should be noted that methanol
exhibits a dose-dependent toxicity on MDCKII cells, but that this
does not reach statistical significance until concentrations in excess
of 6% (data not shown). Therefore, at the dose used within
subsequent in vitro assays (1%), it is possible to produce optimal
spectral characteristics without significant cell death.
Given the impact of local chemical environment on the
quantum yield of R123, it is also important to consider other
commonly used chemicals that may impact upon chemical
environment, such as cell lysis solutions. We examined the impact
of three commonly used cell lysis buffers, RIPA, PEB and 2%
Triton 6100. All three buffers reduced the quantum yield of
R123, with RIPA buffer causing a 30% decrease (Figure 2f). In
addition, RIPA and PEB caused a significant right shift in lmax,
with only triton-6100 retaining the lmax observed with HBSS
alone: Based upon these experiments, triton 6100 would seem to
be the most sensible lysis buffer if post-lysis fluorescent
measurements are required.
Passive diffusion of R123 across biological membranes
For in vitro assays using tracer dyes, the external (loading)
concentration used is critical. For efflux assays, the concentration
must be sufficient to allow sufficient dye uptake to optimise assay
sensitivity. In addition, for both efflux and uptake assays, it is
important to understand the relationship between external
concentration and the ration of passive and active components
of transport. R123 has been reported to cross membranes easily
due to its lipophilic nature and accumulate in areas with negative
membrane potentials, such as within the matrix of mitochondria
Figure 1. Rhodamine-based flurone dyes.
doi:10.1371/journal.pone.0033253.g001
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[5,7]. However, a contrary finding in vitro is that baseline diffusion
from apical to basolateral membranes in Caco-2 cells within
transwell culture is negligible [23], which would argue against
significant passive diffusion occurring in the cellular context. As
increasing evidence suggests that protein-mediated transport
processes occur even for those chemicals initially thought to cross
membranes solely through passive diffusion [12] it is likely that for
R123 there is a mixture of these two processes occurring.
To deconvolute the active and passive components of R123
membrane transport, we first examined the propensity for R123 to
Figure 2. Spectroscopic characteristics of R123 and R110. 1 mM R123 or R110 were prepared in 1% (v/v) MeOH:HBSS. (A) lmax for excitation
of each fluorophore was determined using a wavelength absorbance scan (400–600 nm), and (B) lmax for emission determined using a wavelength
scan (500–600 nm) with a fixed lex = 505 nm. (C+D) 1 mM R123 or R110 in 1% (v/v) indicated sovent:HBSS were examined with an emission
wavelength scan (500–600 nm) with a fixed lex = 505 nm for (C) R123 and (D) R110. (E) Quantum yield for R123 was determined for each solvent
combination and plotted against solvent dielectric constant. (F) The impact of commonly used extraction buffers on R123 quantum yield was
determined by addition of 1 mM R123 to extraction buffers, followed by an emission wavelength scan (500–600 nm) undertaken with a fixed
lex = 505 nm. All data are representative of at least three independent repeats.
doi:10.1371/journal.pone.0033253.g002
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passively diffuse by determining the partition coefficient in a
simple water:octan-1-ol system. Over the concentration range
tested (10–500 nm R123) between 69 – 51% of R123 partitioned
into the octan-1-ol phase, with octan-1-ol preference decreasing
with increasing R123 concentration (data not shown). At
physiological pH, such partition coefficients results in a LogD7.4
value of approximately 1.5, which is consistent with previous
estimates [24,25]. In general, passive permeability increases
linearly with logD, with Lipinski’s rule of five stating that optimal
absorption is achieved with a logD value greater that five [26].
Hence, the partitioning estimate derived herein and elsewhere is
supportive of only minimal passive diffusion of R123 at the
concentrations examined.
Regardless of the passive permeability of an individual chemical
molecule, once chemical concentration exceeds the critical micelle
concentration (CMC) then the chemical will aggregate into
micelles. From this point on, and almost all additional chemical
introduced to the system forms/enters into micelles. Micelles
display significantly different transport and metabolic capacities
compared to free chemical, and generally exhibit much increased
passive permeability across biological membranes [27]. as micelle
formation in fluorophores is associated with a shift in lmax and/
or altered quantum yield [28], we determined the CMC for R123
through measurement of the fluorescence emission of 0–15 mM
R123 concentration. A segmented linear regression of this
relationship identifies the CMC concentration as 1.960.1 mM
(Figure 3a). Once R123 concentration surpasses the CMC,
micelles will rapidly form, and these will passively diffuse through
the membrane. Hence, for rapid loading of in vitro cell systems, a
loading concentration in excess of 2 mM would seem optimal.
Given that R123-dependent cell toxicity is not significant until
concentrations in excess of 20 mM (data not shown), the use of
2 mM as a loading concentration would have no negative impact
on cell viability.
It is important to note that the total concentration of R123
within cells is higher than the concentration in the loading
medium, by approximately 4-fold (figure 3b), although this is still
five-fold lower than the concentration demonstrated to elicit overt
toxicity. This disparity is due to sequestration of R123, leading to a
heterogeneous sub-cellular localisation [7]. The degree of
intracellular sequestration is cell line dependent, with MDCKII
cells showing considerably more sequestration than in Huh7 cells,
being 50% and 30%, respectively (figure 3c). R123 that is
sequestered into membranes or sub-cellular organelles may still be
effluxed through active transport mechanism. However, before
efflux can occur, the chemical must first diffuse out of the
sequestering body. As demonstrated by Yu et al. this can have a
significant impact on the overall sub-cellular kinetics and should be
considered when calculating accurate kinetic parameters [29].
Determination of the degree of sub-cellular sequestration is,
therefore, an important consideration when optimising a novel cell
line for quantification of efflux transport.
In addition to the potential for tracer dyes to become
sequestered within sub-cellular organelles, it is important to
consider components of the medium, or blood in vivo, to which
tracer dyes may become bound. Many small molecules bind
reversibly to albumin and other serum proteins in vivo, which
function as carriers and increase the apparent solubility of
hydrophobic drugs [30]. It is thus becoming commonplace to
include albumin within in vitro assay systems to mimic this effect
[31]. R123 has previously been found to be highly bound to
plasma proteins, with an unbound fraction (fu) of 0.3 in rats [20].
We, therefore, examined the propensity for R123 to bind albumin
in vitro, using the shift in lmax associated with protein-drug
interactions [30]. The change in fluorescence intensity of 0.1 mM
R123 was determined for increasing albumin concentration
(figure 3d), fitted using a one site total saturation model, generating
a Kd = 2.260.3 mM. The use of albumin binding data is becoming
standard for the in vitro-in vivo extrapolation of drug disposition
and pharmacokinetics. It is well established that clearance rates
estimated from in vitro-derived transport rates alone are often an
under-prediction, often caused by binding to plasma proteins such
as albumin [32]. It is thus important to derive albumin binding
data for both in vitro-in vivo extrapolation (IVIVE) and to allow
correction of transporter data undertaken in serum-containing
medium.
As previously reported, R123 is highly bound to serum in vivo,
approximately 70% in rats [20], and we demonstrate herein that
this interaction has a Kd of approximately 2 mM. The concen-
tration of albumin in serum is approximately 60–70 mM, meaning
that a standard cell culture medium containing 10% calf serum
will have a concentration of approximately 6–7 mM. Such a
concentration will allow significant R123 binding to albumin that
will, therefore, impact upon the free extracellular concentration of
R123. To avoid such issues, it is recommended that tests are
carried out in non-serum containing media, such as HBSS.
Carrier-protein dependent transport of R123 across
biological membranes
In addition to passive diffusion of R123 micelles across
biological membranes, protein-mediated membrane transport
may play a role in R123 disposition. R123 uptake in sandwich
rat hepatocytes has been shown to be a saturable process that can
be inhibited by Oatp1a4 substrates (digoxin, quinine, d-verapamil,
17b-estradiol-D-17b-glucuronide) [33], while the utility of R123 as
an MDR1 substrate is the subject of the current study. We first
examined the potential for active uptake or R123 by OATP
transporters. HEK293 MSRII cells were singly transduced with
human SLCO genes using BacMam technology, and R123 uptake
examined in the presence of absence of appropriate chemical
inhibitors. Figure 4a–d demonstrates that while R123 is a clear
substrate for OATP1A2-mediated transport (Km = 0.360.1 mM,
Vmax = 6.860.5 mM), it is not a substrate for the other major
OATP isoforms in human liver, namely OATP1B1, 1B3 and 2B1.
Such data is consistent with the uptake of R123 by Oatp1a4 in the
rat, which is the orthologue of human OATP1A2 [33].
To characterise the transporter-mediated efflux of R123, we
next measured the ABCB1-mediated efflux of R123 in MDCKII
cells into which the coding sequence (CDS) encoding the human
ABCB1 had been stably integrated. Compared to naive MDCKII
cells, those expressing human ABCB1 were able to efflux R123 at
a significantly faster rate (Figure 4e): This efflux was inhibited by
the ABCB1 competitive inhibitor quinidine (data not shown).
Subtraction of the efflux rate in naive cells from those in ABCB1-
expressing cells provided a Michaelis-Menten constant (Km) of
17.562.8 mM and Vmax = 20.461.4 mM for the ABCB1-medi-
ated active transport of R123.
R110 is known to not act as a MDR1 substrate [34], and hence
the formation of this metabolic product within cell systems should
not impact upon R123-mediated efflux through competitive
mechanisms; there will obviously be an impact in terms of
reduced R123 concentration in such metabolically active systems,
but as addressed in the next section, this can be accounted for.
With regard to the uptake transporters, little information is
available on the ability of R110 to act as a substrate of the
proteins; however, given that R110 will be formed within the
intracellular compartment, while the uptake transporters derive
substrate from the extracellular compartment, and that R110
Characterization of R123 as an MDR1-Tracer Dye
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passive diffusion across membranes is low, it is highly unlikely that
any significant effect will be observed. As OATP1A2 can mediate
the uptake of R123, a pertinent question is whether this will
confound measurements of MDR1-mediated efflux of R123 in
vitro. During the loading phase of any experiment, OATP-
mediated uptake will have little impact, as extracellular concen-
tration is maintained above the CMC, meaning passive uptake is
the predominant route. However, during measurement of MDR1-
mediated efflux it could be questioned whether OATP-mediated
uptake into the cells could confound measurement, effectively
causing an underestimation of efflux rate. Given the large external
medium volume (2 mL) compared to the internal cellular volume
(,2 pL per cell or ,0.4 uL/well) used in the efflux assay, effluxed
R123 is subject to a five thousand-fold dilution. Due to this, the
concentration of R123 in the assay medium is unlikely to achieve
concentrations sufficiently high for OATP1A2-mediated uptake to
become significant, especially when one considers that the Km for
this uptake is 0.3 mM.
It should be noted that R123 may be a substrate for other
uptake transporters, and has recently been reported as an OCT1/
2 substrate [35]. However, given the large number of SLC and
ABCC drug transporters per species (.400), it is unfeasible to test
all of these for their ability to transport R123/R110. They should
however, be considered potential confounding factors in any
Figure 3. Passive uptake and sequestration of R123. (A) Critical micelle concentration of R123 was determined by measuring quantum yield
(lex = 505 nm, lem = 5251nm) of 0–0.5 mM R123 in 1% (v/v)MeOH:HBSS. (B) MDCKII-ABCB1 cells were incubated with 0–20 mM R123 for 10 minutes
and intracellular R123 concentration determined against a standard curve following cell lysis with Triton 6100. (C) MDCKII or Huh7 cells were
incubated with 10 mM R123 for 10 minutes and R123 concentration in soluble and insoluble cellular fractions determined against R123 standard
curves. (D) Albumin binding was determined through the measurement of 0.1 mM R123 fluorescence following the addition of increasing quantities
of 0–15 mM albumin. (E) S9 metabolic fractions were extracted from human liver samples and MDCKII cells and used at a final concentration of and
respectively. The rate of conversion of R123 to R110 was determined following addition of 0.1 mg/ml or 1 mg/ml S9 fraction from MDCKII cells or
human liver, respectively. Rate of conversion was determined for the indicated range of R123, and fitted using an allosteric sigmoidal model of
enzyme kinetics. Data points are the average of three separate repeats 6 S.D; where no error bars are observed, they are contained within the limits
of the data point.
doi:10.1371/journal.pone.0033253.g003
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analysis. It is recommended that experimental design accounts for
such confounding, with the use of over-expression systems and/or
loading concentrations over the CMC, as appropriate, being
possible wasy to mitigate/minimise such effects.
Metabolism of R123
R123 is metabolised by intracellular esterases to R110 (figure 1;
[5]), which is also a fluorophore, albeit with different spectroscopic
properties (figure 2). As R110 is subsequently glucuronidated to
become a substrate for MRP2 [21], R123 has been suggested as a
dual marker for MDR1- and MRP2-mediated transport [36]. It is
important to derive kinetic parameters for this metabolic
conversion, such that accurate estimations of intracellular R123
concentration can be made: This, in turn, will allow the robust
determination of R123 transport kinetics. We used the metabolic
(S9) fraction from both MDCKII and human liver cells to
determine these kinetics, while keeping the R123 concentration
below the CMC (2 mM) to ensure that rate plateauing was as a
result of maximum enzyme velocity and not R123 aggregation
into micelles. Initial rates of fluorescence loss were correlated
against R123 concentration and fitted with a sigmoidal Hill slope
on the basis of Akaikes information criterion, which confirmed the
selection of the allosteric sigmoidal curve fit over a Michaelis-
Menten model with 99% probability [37]. R123 biotransforma-
tion in the MDCKII cell line occurred at a higher rate
(Vmax = 154.6615.51 pmol/min/mg) and with higher enzyme
affinity for the substrate (K9 = 0.04860.053 mM) than was seen
when human liver-derived S9 was used (Vmax = 136.568.6 p-
Figure 4. Carrier-protein dependent transport of R123 through biological membranes. (A–D) HEK-293 MSRII cells were singly transduced
with BacMam viruses carrying human CDS’ for OATP1A2, OATP1B3, OATP2B1 and OATP1B1 and incubated for 48 hours to allow protein expression.
Cells were exposed to 0–2 mM R123, in the presence (open circles) or absence (closed circles) of 10 nM specific inhibitor for 120, 300, 420 and 600
seconds at 37uC, and intracellular fluorescence determined: Inhibitors were ketoconazole (OATP1A2), rifamycin (OATP1B1/3) and montelukast
(OATP2B1). Data points correspond to the rate of uptake obtained from linear regressions over three time points with duplicate values at each
concentration. (E) Naive MDCKII cells (open circles), or MDCKII cells with the CDS for human ABCB1 stably integrated (closed circles) were loaded with
varying concentrations of R123 and efflux measured over 7.5 minutes. For all panels, inset images represent Western blot analysis for naı̈ve and
transfected cells (top row), plus actin loading control (bottom row), demonstrating high-level expression of the requisite human transporter in each
case.
doi:10.1371/journal.pone.0033253.g004
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mol/min/mg, K9 = 0.3260.08 mM) (figure 3e). For both reactions,
the Hill slope (h) was approximately 2, suggestive of positive
cooperativity upon substrate binding to one or more binding sites
on the enzyme(s). Whilst it is difficult to accurately assess the
metabolism rate of R123 in cells, due to the large number of
factors that influence this rate, it is possible to reach a reasonable
estimation based upon several assumptions, such as the volume of
cells, their protein content, the equilibration between intracellular
R123 pools etc. Based upon these assumptions, we estimate that at
Vmax rates, metabolism of R123 in vitro would consume
approximately 1% of the R123 pool every minute. This is likely
an overestimation, as Vmax would not always be achieved/
maintained, but even under such conditions, less that 10% of the
R123 would be lost through metabolism during the 7.5 minute
experimental period.
Comparison of R123 to other tracer dyes
R123 is not the only chemical that has been proposed for use as
a tracer dye for MDR1. The most commonly used alternatives are
currently Hoechst 33342 [38], 3,39-diethyloxacarbocyanine iodide
and, calcein-AM [39], with commercially systems such as eFluxx-
ID also being recently released (Enzo Lifesciences; [40]). However,
it should be noted that Prochazkova and colleagues recently
demonstrated that dihydrorhodamine 123, dihexiloxocarbocya-
nine iodide, hydroethidine, tetrachloro-tetraethylbenzimidazolo-
carbo-cyanine iodide and tetramethylrhodamine ethyl ester
perchlorate were all substrates for MDR1, and hence could
represent potential tracer dyes [41]. It should be noted that all of
these dyes have the potential limitation that they possess liabilities
for transport by other members of the ABC and SLC superfamilies
of membrane transport proteins. Such transport may confound
measurement of MDR1-mediated activity unless suitable controls
are employed (e.g. the use of overexpression systems or specific
pharmacological inhibitors to allow the derivation of the MDR1-
component for any efflux. As noted herein, access of lipophilic
tracer dyes, including R123, into the cell interior may be a limiting
factor to their utility. A solution to this is the modification of the
tracer dye to a membrane-permeable precursor, as seen with the
hydrophobic ester derivative calcein acetoxymethyl (Calcein-AM):
once in the cell these esters are rapidly cleaved to reveal the
fluorescent probe substrate [40]. However, as described herein,
simple derivation of the CMC for R123 allows efficient loading of
cell without the need for derivatisation of the base fluorophore;
indeed this is an approach that we would propose as a general first
step in optimising tracer dye use. One advantage of R123 over
tracer dyes such as Hoechst 33342 is its fluorescent stability, with
R123 showing very little photodegradation over time (data not
shown compared to Hoeschst 33258, which is liable to both
photodegradation and quenching [42].
Conclusion
Tracer dyes are commonly used as biologically-silent probes to
examine processes within the cellular context. Their low cost, good
availability and ease of measurement make them ideal for use in
both high throughput and high content biological studies. In order
to maximise data from these studies, it is important to fully
characterise the spectral properties of these tracer dyes, plus their
interaction with the cellular environment. Herein, we confirm the
lmax for R123 excitation and emission, and demonstrate that
these are altered significantly by local chemical environment, with
1% (v/v) methanol in HBSS providing the best compromise of
solubility, quantum yield and cellular toxicity. In addition, we
demonstrate that R123 has a CMC of 1.9 mM, meaning that
cellular loading is rapid at concentrations above 2 mM. Finally, we
demonstrate that R123 is rapidly distributed within cells,
partitioning into subcellular membranes and organelles, as well
as being metabolised into R110, a related flurone. These data
allow an accurate estimation of the sub-cellular pharmacokinetics
of R123, an important step in its optimisation as a tracer dye.
Materials and Methods
Cell Lines and Routine Maintenance
The human hepatocellular carcinoma (Huh7) cell line is a
differentiated, immortalised cell line commonly used as an in vitro
hepatocyte model [43,44], and was a kind gift of GlaxoSmith-
Kline. Madin-Darby canine kidney cells, strain II (MDCKII) share
some characteristics with both proximal and distal tubule cells
[45], are commonly used as a polarising cell line for transporter
studies, and were purchased from ECACC (ECACC code
00062107, Porton Down, UK). Both cell lines were cultured in
Dulbecco’s modified eagle medium (DMEM) with L-glutamine
and phenol red, containing 10% foetal bovine serum, 1% non-
essential amino acids (NEAAs), 100 U/ml penicillin and 100 mg/
ml streptomycin. All cell culture reagents were purchased from
Invitrogen (Paisley, UK).
Human Embryonic Kidney (HEK; ECACC code 85120602)
are derived from healthy human embryonic kidney and later
modified to express human Class A macrophage scavenger
receptor (HEK293-MSRII) to improve cell adherence [46], and
were a kind gift of GlaxoSmithKline. Cells were cultured in
DMEM:Hams F12 nutrient mixture (1:1) with L-glutamine and
phenol red, containing 10% foetal bovine serum and 0.4 mg/ml
Geneticin.
For all cell lines, cells were routinely cultured in 75 cm2 growth
area tissue culture flasks, and passaged when they reached
approximately 80% confluence. To ensure phenotypic consistency
throughout experiments, each cell line was only used for a fixed
number of passages after recovery from storage: Huh7 cells were
used up to 12 passages after receipt, while MDCKII and
HEK293-MSRII cells were used up to passage 54 from a new
stock.
Cell lysis Solutions
For the determination of cell lysis solution impact on R123
fluoresence we prepared three commonly used cell lysis solutions:
RIPA buffer (50 mM Tris.HCl pH7.4, 150 mM NaCl, 2 mM
EDTA, 1% nonidet p40, 0.1% SDS), PEB (2% nonidet p40, 0.2%
SDS, 1 mM dithiothrietol) and 2% Trition 6100.
Facilitated transport capacity using BacMam Transduced
HEK293-MSRII Cells
For active uptake experiments, cells were transduced with
BacMam virus (Invitrogen) containing the coding sequence for
each of the four major SLC transporters in human liver; namely,
OATP1A2, OATP1B1, OATP1B3, and OATP2B1. The method
of transduction, maximum permitted percentage of BacMam,
plaque forming units (pfu) per millilitre and the multiplicity of
infection (MOI) were optimised for each expression plasmid in
pilot experiments, as summarised in Table 1. In all cases, BacMam
reagent was kept protected from light at 4uC, and sodium butyrate
(2 mM) added to medium prior to BacMam to increase
transduction efficiency, and then transduction undertaken as per
the manufacturer’s instructions. For OATP1B1 in well-transduc-
tion, cells were plated at 26105 cells/cm2 and allowed to adhere
for 4 hours prior to removal of medium and addition of BacMam,
whilst for in-tube transductions, cells were transduced and then
plated at the concentrations indicated in table 1. All transduced
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cells were placed in a humidified incubator at 37uC with 5% CO2
for 48 hours prior to uptake analysis to allow expression and
correct localisation of the encoded SLC transporter.
Following transduction, uptake assays were undertaken as
follows: Medium was removed and cells washed with prewarmed
37uC Dulbecco’s phosphate buffered saline (DPBS; Invitrogen). 0–
2 mM R123 (1% methanol, DPBS) (Sigma-Aldrich, Poole, UK)
was added per well, and incubated in a humidified incubator at
37uC. At the end of the timed incubation, solutions were removed
from the wells, followed by the immediate addition of ice-cold
DPBS to each well. Cells were washed a further two times with ice-
cold DPBS before fluorescence was measured; intracellular R123
concentration was then determined against a R123 standard curve
prepared in the same medium. For each transduction experiment,
transporter functionality was determined by uptake of radiola-
belled model substrates (estradiol 17b-D-glucoronide for
OATP1B1/3 and estrone sulphate for OATP1A2 and 2B1), and
the inhibition of transport activity by specific SLC-inhibitors
(10 nM ketoconazole for OATP1A2; 10 nM rifamycin for
OATP1B1/3; 10 nM montelukast for OATP2B1).
Intracellular Accumulation of R123 in MDCKII/MDCKII-
ABCB1 Cells
Cells were initially plated at 26105 cells per cm2 in 24-well
plates and allowed to reach 80% confluence. Cells were then
exposed to 0–10 mM R123 (1% methanol, HBSS) for 10 minutes,
followed by washing three times with ice-cold DPBS to remove
excess R123, and lysis with 2% (v/v) triton-6100 in HBSS with
16protease inhibitors (Roche Diagnostics, Burgess Hill, UK). The
lysate was then diluted 1:2 with HBSS and the fluorescence
determined against a standard curve prepared by spiking R123
into cell lysate with 2% (v/v) triton 6100.
Efflux Assays with R123 in MDCKII/MDCKII-ABCB1 Cells
MDCKII and MDCKII-ABCB1 were initially plated at 26105
cells per cm2 in 6-well plates and allowed to reach 80%
confluence. Cells were then exposed to 0–20 mM of R123 (1%
methanol, HBSS) for 10 minutes at 37uC, to allow loading of
R123 into cells. Following loading, cells were washed three times
with cold PBS to remove excess R123, and efflux initiated by the
addition of 3 ml HBSS pre-warmed to 37uC. R123 fluorescence
was determined after 7.5 minutes, a time previously determined to
be within the linear phase of the assay. Cells were subsequently
lysed with 2% (v/v) triton-6100 in HBSS with 16protease
inhibitors, total protein measured by the Lowry method [47], and
R123 concentration normalised to protein content. Finally, R123
concentration was determined against a standard curve measured
under the same conditions.
Metabolism of R123 to R110
R123 is metabolised to R110 by the removal of a methyl ester
group [48]. R110 is also a fluorophore, but with a lower quantum
yield for any given excitation wavelength. Thus, the rate of
conversion of R123 to R110 can be determined by measuring the
fluorescence decrease over time. Metabolism was measured in
HBSS supplemented with 5 mM MgCl2, 5 mM glucose-6-
phosphate, 0.5 mM b-NADP+ and 0–1.4 mM R123 (1% metha-
nol, HBSS), as indicated. The reaction was initiated by addition of
MDCKII- or human liver-derived S9 fraction at a final
concentration of 0.1 mg/ml and 1 mg/ml, respectively, and
fluorescence decrease over 2 minutes measured.
S9 fractions were prepared from either human liver or
MDCKII cells. Scissor-minced human liver in 1.15% KCl, or
MDCKII cells in DMEM were initially homogenised using either
a Dounce homogeniser or 21 guage needle, respectively. Cell
suspensions were then centrifuged for 5 minutes at 8006g.
Medium was removed and the pellet resuspended in cold HBSS.
Cells were then homogenised and lysed by passing ten times
through a 21 gauge needle. This lysate was then centrifuged for
20 minutes at 90006g at 4uC and the supernatant (containing
microsomes and soluble fraction) assayed for protein concentration
using the Lowry method [47].
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